Demand For Surgical Heart Valves Projected To Slowly Decline
The market for surgical heart valve replacement devices is projected to steadily decline, as newer, more innovative transcatheter techniques poach customers, according to a new report from Informa’s Meddevicetracker.
You may also be interested in...
The US FDA approved Abbott’s new Epic Plus stented tissue mitral valve and Epic Plus Supra stented tissue aortic valve.
Using its DHLT cryptocurrency token, DeHealth wants to create a transparent ledger of medical data transfers so patients can see who has their data.
Minute Insight: Novartis, Medtronic, NHS Trust And RYSE Join Forces To Spur Development Of Digital Heart Health Solutions
Novartis Biome UK Heart Health Catalyst is taking applications from start-ups, researchers and technologists through 31 August. As much as £3m is up for grabs and specific interest in non-invasive lipid measurement techniques and at-home blood pressure testing using software as a medical device.